Literature DB >> 12352970

Diversity of receptors binding HIV on dendritic cell subsets.

Stuart G Turville1, Paul U Cameron, Amanda Handley, George Lin, Stefan Pöhlmann, Robert W Doms, Anthony L Cunningham.   

Abstract

The ability of HIV-1 to use dendritic cells (DCs) for transport and to transfer virus to activated T cells in the lymph node may be crucial in early HIV-1 pathogenesis. We have characterized primary DCs for the receptors involved in viral envelope attachment and observed that C-type lectin receptor (CLR) binding was predominant in skin DCs, whereas binding to emigrating and tonsil DCs was CD4-dependent. No one CLR was solely responsible for envelope binding on all skin DC subsets. DC-SIGN (DC-specific ICAM-3-grabbing nonintegrin) was only expressed by CD14(+)CDla(lo) dermal DCs. The mannose receptor was expressed by CD1a(hi) and CD14(+)CDla(lo) dermal DCs, and langerin was expressed by Langerhans cells. The diversity of CLRs able to bind HIV-1 in skin DCs may reflect their ability to bind a range of microbial glycoproteins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12352970     DOI: 10.1038/ni841

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  196 in total

1.  Human cytomegalovirus transmission from the uterus to the placenta correlates with the presence of pathogenic bacteria and maternal immunity.

Authors:  Lenore Pereira; Ekaterina Maidji; Susan McDonagh; Olga Genbacev; Susan Fisher
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

2.  Inhibition of human immunodeficiency virus type 1 Env-mediated fusion by DC-SIGN.

Authors:  Cinzia Nobile; Arnaud Moris; Françoise Porrot; Nathalie Sol-Foulon; Olivier Schwartz
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 3.  Dangerous liaisons at the virological synapse.

Authors:  Vincent Piguet; Quentin Sattentau
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

Review 4.  DC-SIGN: binding receptor for HCV?

Authors:  Zhi-Hua Feng; Quan-Chu Wang; Qing-He Nie; Zhan-Sheng Jia; Yong-Xin Zhou
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

5.  CD1a and langerin: acting as more than Langerhans cell markers.

Authors:  Norikatsu Mizumoto; Akira Takashima
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

6.  DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus.

Authors:  Andrea Marzi; Thomas Gramberg; Graham Simmons; Peggy Möller; Andrew J Rennekamp; Mandy Krumbiegel; Martina Geier; Jutta Eisemann; Nadine Turza; Bertrand Saunier; Alexander Steinkasserer; Stephan Becker; Paul Bates; Heike Hofmann; Stefan Pöhlmann
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

7.  Infection of specific dendritic cells by CCR5-tropic human immunodeficiency virus type 1 promotes cell-mediated transmission of virus resistant to broadly neutralizing antibodies.

Authors:  Lakshmanan Ganesh; Kwanyee Leung; Karin Loré; Reuven Levin; Amos Panet; Owen Schwartz; Richard A Koup; Gary J Nabel
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

8.  Mucosal and systemic anti-HIV immunity controlled by A20 in mouse dendritic cells.

Authors:  Bangxing Hong; Xiao-Tong Song; Lisa Rollins; Lindsey Berry; Xue F Huang; Si-Yi Chen
Journal:  J Clin Invest       Date:  2011-01-04       Impact factor: 14.808

9.  HIV-1 N-glycan composition governs a balance between dendritic cell-mediated viral transmission and antigen presentation.

Authors:  Thijs van Montfort; Dirk Eggink; Maikel Boot; Michael Tuen; Catarina E Hioe; Ben Berkhout; Rogier W Sanders
Journal:  J Immunol       Date:  2011-09-28       Impact factor: 5.422

Review 10.  Dendritic cells and macrophages in the genitourinary tract.

Authors:  N Iijima; J M Thompson; A Iwasaki
Journal:  Mucosal Immunol       Date:  2008-09-10       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.